BASELINE PROSTATE SPECIFIC ANTIGEN LEVEL AND THE RISK OF PROSTATE CANCER AND PROSTATE SPECIFIC MORTALITY

被引：0
|
作者：
Connolly, D. [1 ]
Black, A. [2 ]
Van Leeuwen, P. J. [3 ]
Gavin, A. [3 ]
Murray, L. J. [2 ]
Keane, P. F. [1 ]
机构：
[1] Belfast City Hosp, Dept Urol, Belfast BT9 7AD, Antrim, North Ireland
[2] Queens Univ Belfast, Canc Epidemiol Prevent Res Grp, Belfast, Antrim, North Ireland
[3] Queens Univ Belfast, No Ireland Canc Registry, Belfast, Antrim, North Ireland
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2009年 / 8卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：164 / 164
页数：1
相关论文
共 50 条
  • [21] Prostate-specific antigen and prostate cancer
    Rosalki, SB
    Rutherford, FJ
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2000, 54 (09) : 611 - 613
  • [22] Serial prostate specific antigen, free-to-total prostate specific antigen ratio and complexed prostate specific antigen for the diagnosis of prostate cancer
    Ellis, WJ
    Etzioni, R
    Vessella, RL
    Hu, CC
    Goodman, GE
    [J]. JOURNAL OF UROLOGY, 2001, 166 (01): : 93 - 98
  • [23] The risk of rapid prostate specific antigen increase in men with baseline prostate specific antigen 2.0 ng/ml or less
    Ito, K
    Yamamoto, T
    Suzuki, K
    Kurokawa, K
    Yamanaka, H
    [J]. JOURNAL OF UROLOGY, 2004, 171 (02): : 656 - 660
  • [24] Posttreatment Prostate Specific Antigen Nadir Predicts Prostate Cancer Specific and All Cause Mortality
    Tseng, Yolanda D.
    Chen, Ming-Hui
    Beard, Clair J.
    Martin, Neil E.
    Orio, Peter F.
    Loffredo, Marian
    Renshaw, Andrew A.
    Choueiri, Toni K.
    Hu, Jim C.
    Kantoff, Philip W.
    D'Amico, Anthony V.
    Nguyen, Paul L.
    [J]. JOURNAL OF UROLOGY, 2012, 187 (06): : 2068 - 2073
  • [25] Prostate-Specific Antigen Level and Risk of Bone Metastasis in Sudanese Patients with Prostate Cancer
    Khalid, Khalid Eltahir
    Brair, Aida Ibrahim
    Elhaj, Ahmed Mohamed
    Ali, Khalid Eltom
    [J]. SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2011, 22 (05) : 1041 - 1043
  • [26] ENDOGENOUS AND EXOGENOUS TESTOSTERONE AND THE RISK OF PROSTATE CANCER AND PROSTATE SPECIFIC ANTIGEN
    Boyle, Peter
    Koechlin, Alice
    Bota, Maria
    d'Onofrio, Alberto
    Zaridze, David G.
    Perrin, Paul
    Fitzpatrick, John
    Burnett, Arthur L.
    Boniol, Mathieu
    [J]. JOURNAL OF UROLOGY, 2015, 193 (04): : E30 - E30
  • [27] Prostate-specific antigen gene polymorphism and prostate cancer risk
    Sivonova, M.
    Matakova, T.
    Dobrota, D.
    Hatok, J.
    Kliment, J., Jr.
    Tomaskin, R.
    Kliment, J.
    [J]. EJC SUPPLEMENTS, 2008, 6 (03): : 53 - 54
  • [28] Use of Baseline Prostate-Specific Antigen Measurements to Personalize Prostate Cancer Screening
    Loeb, Stacy
    [J]. EUROPEAN UROLOGY, 2012, 61 (05) : 875 - 876
  • [29] Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer
    Preston, Mark A.
    Batista, Julie L.
    Wilson, Kathryn M.
    Carlsson, Sigrid V.
    Gerke, Travis
    Sjoberg, Daniel D.
    Dahl, Douglas M.
    Sesso, Howard D.
    Feldman, Adam S.
    Gann, Peter H.
    Kibel, Adam S.
    Vickers, Andrew J.
    Mucci, Lorelei A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (23) : 2705 - +
  • [30] Value of Prostate Specific Antigen Density and Percent Free Prostate Specific Antigen for Prostate Cancer Prognosis
    Busch, Jonas
    Hamborg, Kristin
    Meyer, Hellmuth-Alexander
    Buckendahl, John
    Magheli, Ahmed
    Lein, Michael
    Jung, Klaus
    Miller, Kurt
    Stephan, Carsten
    [J]. JOURNAL OF UROLOGY, 2012, 188 (06): : 2165 - 2170
12345